These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 11768862)

  • 1. IL-12 may be useful for hepatitis C.
    TreatmentUpdate; 2001 Sep; 13(5):4-5. PubMed ID: 11768862
    [No Abstract]   [Full Text] [Related]  

  • 2. A multicenter study of recombinant human interleukin 12 for the treatment of chronic hepatitis C virus infection in patients nonresponsive to previous therapy.
    Pockros PJ; Patel K; O'Brien C; Tong M; Smith C; Rustgi V; Carithers RL; McHutchison JG; Olek E; Debruin MF
    Hepatology; 2003 Jun; 37(6):1368-74. PubMed ID: 12774016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the effect of IL-12 therapy on immunoregulatory T-cell subsets in patients with chronic hepatitis C infection.
    Barth H; Klein R; Berg PA; Wiedenmann B; Hopf U; Berg T
    Hepatogastroenterology; 2003; 50(49):201-6. PubMed ID: 12630023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: antiviral and immunological activity.
    Rigopoulou EI; Suri D; Chokshi S; Mullerova I; Rice S; Tedder RS; Williams R; Naoumov NV
    Hepatology; 2005 Nov; 42(5):1028-36. PubMed ID: 16250037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B.
    Carreño V; Zeuzem S; Hopf U; Marcellin P; Cooksley WG; Fevery J; Diago M; Reddy R; Peters M; Rittweger K; Rakhit A; Pardo M
    J Hepatol; 2000 Feb; 32(2):317-24. PubMed ID: 10707873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal IL-12 produces discreet pulmonary and systemic effects on allergic inflammation and airway reactivity.
    Matsuse H; Kong X; Hu J; Wolf SF; Lockey RF; Mohapatra SS
    Int Immunopharmacol; 2003 Apr; 3(4):457-68. PubMed ID: 12689651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides.
    Duvic M; Sherman ML; Wood GS; Kuzel TM; Olsen E; Foss F; Laliberté RJ; Ryan JL; Zonno K; Rook AH
    J Am Acad Dermatol; 2006 Nov; 55(5):807-13. PubMed ID: 17052486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor.
    van Herpen CM; van der Laak JA; de Vries IJ; van Krieken JH; de Wilde PC; Balvers MG; Adema GJ; De Mulder PH
    Clin Cancer Res; 2005 Mar; 11(5):1899-909. PubMed ID: 15756016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Will the sunscreens of the future contain interleukin-12?
    Senior K
    Lancet; 2001 Dec; 358(9296):1878. PubMed ID: 11741633
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: Effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines.
    Indrová M; Bubeník J; Mikysková R; Mendoza L; Símová J; Bieblová J; Jandlová T; Jinoch P; Smahel M; Vonka V; Pajtasz-Piasecka E
    Int J Oncol; 2003 Mar; 22(3):691-5. PubMed ID: 12579325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous injection of interleukin 12 induces systemic inflammatory responses in humans: implications for the use of IL-12 as vaccine adjuvant.
    Portielje JE; Kruit WH; Eerenberg AJ; Schuler M; Sparreboom A; Lamers CH; Gratama JW; Stoter G; Huber C; Hack CE
    Cancer Immunol Immunother; 2005 Jan; 54(1):37-43. PubMed ID: 15693137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hepatitis C drug development pipeline.
    Raymond D
    Res Initiat Treat Action; 2004; 10(2):21-5. PubMed ID: 15828097
    [No Abstract]   [Full Text] [Related]  

  • 13. A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial).
    Altman RD; Rosen JE; Bloch DA; Hatoum HT; Korner P
    Semin Arthritis Rheum; 2009 Aug; 39(1):1-9. PubMed ID: 19539353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic cryptosporidiosis in AIDS with rIL-12 induces an immune response associated with improvement but severe side-effects.
    Okhuysen PC; Chappell CL; Lewis DE; Robinson P; White AC
    AIDS; 2005 Aug; 19(12):1333-4. PubMed ID: 16052094
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvanted hepatitis B vaccine: new drug. Patients with renal failure: similar response rate but fewer boosters needed.
    Prescrire Int; 2008 Dec; 17(98):234-6. PubMed ID: 19422145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knee osteoarthritis: should your patient opt for hyaluronic acid injection?
    Medina JM; Thomas A; Denegar CR
    J Fam Pract; 2006 Aug; 55(8):669-75. PubMed ID: 16882439
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and immunogenicity of Towne cytomegalovirus vaccine with or without adjuvant recombinant interleukin-12.
    Jacobson MA; Sinclair E; Bredt B; Agrillo L; Black D; Epling CL; Carvidi A; Ho T; Bains R; Girling V; Adler SP
    Vaccine; 2006 Jun; 24(25):5311-9. PubMed ID: 16701925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TH1/TH2 serum cytokine profiles and soluble TNF-receptor response in patients with chronic hepatitis C during recombinant human interleukin-12 (rHuIL-12) treatment.
    Teuber G; Rossol S; Lee JH; Dietrich CF; Zeuzem S
    Z Gastroenterol; 2002 Jul; 40(7):487-95. PubMed ID: 12122596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus core protein and hepatitis activity are associated through transactivation of interleukin-8.
    Hoshida Y; Kato N; Yoshida H; Wang Y; Tanaka M; Goto T; Otsuka M; Taniguchi H; Moriyama M; Imazeki F; Yokosuka O; Kawabe T; Shiratori Y; Omata M
    J Infect Dis; 2005 Jul; 192(2):266-75. PubMed ID: 15962221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of interleukin-12 in cancer immunotherapy].
    Mazzolini G; Melero I; Prieto J
    Medicina (B Aires); 2004; 64(1):77-8. PubMed ID: 15034963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.